For anyone interested in investing in the health-care space, JPMorgan's annual Health Care Conference has become one of the most important events of the year. We were not able to get to San Francisco this year, but one of our favorite Odd Lots guests, James van Geelen of CitriniResearch.com, was in attendance. He called into this week's episode of Lots More to tell us what the leading players in health care and medical technology are buzzing about right now — and he confirms that AI and GLP-1 weight loss drugs are at the top of everyone's mind."
See omnystudio.com/listener for privacy information.
Eight Months In, What Is Happening With Biden's CHIPS Act?
What Commercial Real Estate Stress Means for Banks and Bond Funds
Nassim Taleb on What Bitcoiners, Anti-Vaxxers and Deadlift Maxis All Get Wrong
The NYC Landlord Who Says the "Golden Age" of Being a Landlord Is Over
Matt King Sees a $1 Trillion Liquidity Drain Heading for Markets
Betsy Cohen On Tech Investing and How SVB Failed Banking 101
Is It Time For Public Checking Accounts at the Fed?
Where Stress Is Showing in the $20 Trillion Commercial Real Estate Market
What the Dramatic Boom in Zero-Day Options Means for Stocks
The Regulatory Blunder That Gave Us the Silicon Valley Bank Disaster
Dan Davies On What Brought Down Silicon Valley Bank
How the Federal Reserve Grew More Powerful Than Anyone Ever Imagined
Companies Are Telling Us the Real Reason They're Still Raising Prices
Coinbase CEO Brian Armstrong on the Two Big Challenges Facing Crypto
How Empty Land in the Arizona Desert Gets Turned Into Homes
Why We Don't Build More Apartments for Families
Why Interest Rates on Savings Accounts Are Still So Low
A Former CIA Official on One Year of Russia's War in Ukraine
Brian Deese on the Legislative Legacy of President Biden's First Two Years
This Is What Happens if the US Actually Hits the Debt Ceiling
Create your
podcast in
minutes
It is Free
The Business Of
The Compound and Friends
TED Radio Hour
FT Alphachat
Freakonomics Radio
Goldman Sachs Exchanges